Moderna says the FDA is looking into reports of a rare side effect — myocarditis, or the inflammation of the heart muscle — in those who've gotten the shot.
The U.S. has pledged to deliver 1.1 billion doses of COVID vaccines to countries in need. Billions more are needed. NPR interviewed the State Department's global vaccine coordinator to learn more.
The Food and Drug Administration also gave an OK to boosters that differ from the vaccine originally used to immunize people against COVID-19. A mix-and-match approach could ease the booster rollout.
"I knew I had wanted to do something with light because I felt like it's just been such a dark year and a half that I wanted to bring light to whatever it was I was doing," Laura Weiss told NPR.
The delta variant is the fast-moving strain of the coronavirus now found in 96 countries. It's expected to be the dominant variant in the U.S. within weeks.
Oxford-AstraZeneca promised its COVID-19 vaccine would be effective, cheap and available worldwide. Five months after its launch, the path forward has been anything but smooth.
One of the hottest areas of research right now: studies to determine how well current vaccines work against emerging coronavirus "variants of concern."